Sailu Sarvagalla

BIRC5/Survivin is a novel ATG12–ATG5 conjugate interactor and an autophagy-induced DNA damage suppressor in human cancer and mouse embryonic fibroblast cells

Tzu‐Yu Lin, Hsiu-Han Chan, Shang‐Hung Chen et al. · Autophagy · 2019 · 143 citations · Full text

Identification of ligand efficient, fragment-like hits from an HTS library: structure-based virtual screening and docking investigations of 2H- and 3H-pyrazolo tautomers for Aurora kinase A selectivity

Sailu Sarvagalla, Vivek Kumar Singh, Yi-Yu Ke et al. · Journal of Computer-Aided Molecular Design · 2014 · 77 citations

Drug Target, Hit Identification, Biochemistry +11

Disruption of protein–protein interactions: hot spot detection, structure-based virtual screening and in vitro testing for the anti-cancer drug target – survivin

Sailu Sarvagalla, Chun Hei Antonio Cheung, Ju-Ya Tsai et al. · RSC Advances · 2016 · 36 citations

Protein–protein Interactions, Virtual Screening, Drug Target +14

Targeting autophagy with small molecules for cancer therapy

Sree Karani Kondapuram, Sailu Sarvagalla, Mohane Selvaraj Coumar · Journal of Cancer Metastasis and Treatment · 2019 · 26 citations · Full text

Mitophagy, Surgical Oncology, Cancer Management +20

Identification of natural inhibitors of Bcr‐Abl for the treatment of chronic myeloid leukemia

Phanikrishna Parcha, Sailu Sarvagalla, Bindu Madhuri et al. · Chemical Biology & Drug Design · 2017 · 20 citations

Mixed-phenotype Acute Leukemia, Molecular Biology, Pharmacotherapy +16